Skip to content
Biodatica
Start free

Investigator

Glenn John Wagner

RAND CORPORATION · funded by NCI, NIMH

Companies
5

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$1.5M

Summed across those awards.

First award
Jul 6, 2021

Latest Aug 8, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda

    $597k

    Aug 8, 2023NCIRAND CORPORATIONNIH RePORTER · 11136425 (opens the source filing in a new tab)

  2. R01

    A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda

    $17k

    Aug 8, 2023NCIRAND CORPORATIONNIH RePORTER · 11404687 (opens the source filing in a new tab)

  3. R01

    A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda

    $16k

    Aug 8, 2023NCIRAND CORPORATIONNIH RePORTER · 11404688 (opens the source filing in a new tab)

  4. R01

    A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda

    $163k

    Aug 8, 2023NCIRAND CORPORATIONNIH RePORTER · 11398715 (opens the source filing in a new tab)

  5. R01

    Controlled Trial of Game Changers: A Group Intervention to Train HIV Clients to be Change Agents for HIV Prevention in Uganda

    $720k

    Jul 6, 2021NIMHRAND CORPORATIONNIH RePORTER · 11091517 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources